The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2019

Filed:

Dec. 11, 2015
Applicant:

Keio University, Tokyo, JP;

Inventors:

Shigeto Shimmura, Tokyo, JP;

Shin Hatou, Tokyo, JP;

Kazuo Tsubota, Tokyo, JP;

Assignee:

KEIO UNIVERSITY, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/079 (2010.01); A61K 38/22 (2006.01); A61K 38/28 (2006.01); A61K 47/36 (2006.01); A61K 31/203 (2006.01); A61K 35/44 (2015.01); C12N 5/10 (2006.01); A61K 35/30 (2015.01); A61K 48/00 (2006.01); A61P 27/02 (2006.01); A61F 9/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0621 (2013.01); A61K 31/203 (2013.01); A61K 35/30 (2013.01); A61K 35/44 (2013.01); A61K 38/22 (2013.01); A61K 38/28 (2013.01); A61K 47/36 (2013.01); A61K 48/0091 (2013.01); A61P 27/02 (2018.01); C12N 5/10 (2013.01); A61F 9/0017 (2013.01);
Abstract

The problem of the present invention is to provide a method of efficiently producing therapeutic alternative corneal endothelial cells, particularly, a method capable of stably producing them in a condition suitable for intraocular transplantation (in the anterior chamber) in a large amount. Furthermore, the present invention aims to provide a composition for transplantation, which is preferable for intraocular administration, particularly, into the anterior chamber. A therapeutic alternative corneal endothelial cell sphere can be produced by culturing stem cells in suspension in a differentiation induction medium containing a GSK3 inhibitor, retinoic acid and a ROCK inhibitor. Addition of a viscoelastic substance during intraocular (into the anterior chamber) transplantation of the sphere or cultured corneal endothelial cells dispersed into single cells can increase the number of adherent cells after transplantation.


Find Patent Forward Citations

Loading…